B02 Adrenal Pep

Aceticum Acidum, Adrenalinum, American Ginseng, Arnica Montana, Balsamum Peruvianum, Bos Taurus Pituitarum Posterium, Cherry Plum Flower, Chininum Arsenicosum, Cinchona Officinalis, Clematis Vitalba Flower, Damiana, European Hornbeam Flower, European Olive Flower, Glycyrrhiza Glabra, Impatiens Glandulifera Flower, Kali Phosphoricum, Lycopodium Clavatum, Magnesia Phosphorica, Phosphoricum Acidum, Phosphorus, Pyrenees Star Of Bethlehem, Rockrose Flower, Selenium Metallicum, Thyroidinum

Apex Energetics Inc.
Human Otc Drug
NDC 63479-0202

B02 Adrenal Pep also known as Aceticum Acidum, Adrenalinum, American Ginseng, Arnica Montana, Balsamum Peruvianum, Bos Taurus Pituitarum Posterium, Cherry Plum Flower, Chininum Arsenicosum, Cinchona Officinalis, Clematis Vitalba Flower, Damiana, European Hornbeam Flower, European Olive Flower, Glycyrrhiza Glabra, Impatiens Glandulifera Flower, Kali Phosphoricum, Lycopodium Clavatum, Magnesia Phosphorica, Phosphoricum Acidum, Phosphorus, Pyrenees Star Of Bethlehem, Rockrose Flower, Selenium Metallicum, Thyroidinum is a human otc drug labeled by 'Apex Energetics Inc.'. National Drug Code (NDC) number for B02 Adrenal Pep is 63479-0202. This drug is available in dosage form of Solution/ Drops. The names of the active, medicinal ingredients in B02 Adrenal Pep drug includes Acetic Acid - 30 [hp_X]/mL American Ginseng - 2 [hp_X]/mL Arnica Montana - 12 [hp_X]/mL Balsam Peru - 9 [hp_X]/mL Bos Taurus Pituitary Gland, Posterior - 15 [hp_X]/mL Carpinus Betulus Flower - 8 [hp_C]/mL Cinchona Officinalis Bark - 12 [hp_X]/mL Clematis Vitalba Flower - 8 [hp_C]/mL Dibasic Potassium Phosphate - 12 [hp_X]/mL Epinephrine - 6 [hp_X]/mL and more. The currest status of B02 Adrenal Pep drug is Active.

Drug Information:

Drug NDC:	63479-0202
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	B02 Adrenal Pep
Also known as the trade name. It is the name of the product chosen by the labeler.
Proprietary Name Base:	B02
The base of the Brand/Proprietary name excluding its suffix.
Proprietary Name Suffix:	ADRENAL PEP
A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Aceticum Acidum, Adrenalinum, American Ginseng, Arnica Montana, Balsamum Peruvianum, Bos Taurus Pituitarum Posterium, Cherry Plum Flower, Chininum Arsenicosum, Cinchona Officinalis, Clematis Vitalba Flower, Damiana, European Hornbeam Flower, European Olive Flower, Glycyrrhiza Glabra, Impatiens Glandulifera Flower, Kali Phosphoricum, Lycopodium Clavatum, Magnesia Phosphorica, Phosphoricum Acidum, Phosphorus, Pyrenees Star Of Bethlehem, Rockrose Flower, Selenium Metallicum, Thyroidinum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Apex Energetics Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Solution/ Drops
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ACETIC ACID - 30 [hp_X]/mL AMERICAN GINSENG - 2 [hp_X]/mL ARNICA MONTANA - 12 [hp_X]/mL BALSAM PERU - 9 [hp_X]/mL BOS TAURUS PITUITARY GLAND, POSTERIOR - 15 [hp_X]/mL CARPINUS BETULUS FLOWER - 8 [hp_C]/mL CINCHONA OFFICINALIS BARK - 12 [hp_X]/mL CLEMATIS VITALBA FLOWER - 8 [hp_C]/mL DIBASIC POTASSIUM PHOSPHATE - 12 [hp_X]/mL EPINEPHRINE - 6 [hp_X]/mL Load more... GLYCYRRHIZA GLABRA - 1 [hp_X]/mL HELIANTHEMUM NUMMULARIUM FLOWER - 8 [hp_C]/mL IMPATIENS GLANDULIFERA FLOWER - 8 [hp_C]/mL LYCOPODIUM CLAVATUM SPORE - 12 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - 12 [hp_X]/mL OLEA EUROPAEA FLOWER - 8 [hp_C]/mL ORNITHOGALUM UMBELLATUM FLOWERING TOP - 8 [hp_C]/mL PHOSPHORIC ACID - 30 [hp_X]/mL PHOSPHORUS - 30 [hp_X]/mL PRUNUS CERASIFERA FLOWER - 8 [hp_C]/mL QUININE ARSENITE - 12 [hp_X]/mL SELENIUM - 15 [hp_X]/mL THYROID, UNSPECIFIED - 6 [hp_X]/mL TURNERA DIFFUSA LEAFY TWIG - 1 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	15 Dec, 1994
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	25 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Apex Energetics Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
NUI:	N0000185508 N0000175629 N0000184306 M0000728 N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647 N0000185371 N0000185375 M0006342 M0016962
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	Q40Q9N063P 8W75VCV53Q O80TY208ZW 8P5F881OCY 7JM57I419K 07YL55QKZ9 S003A158SB 7SCP4N87CI CI71S98N1Z YKH834O4BH Load more... 2788Z9758H 51BRR32WPP AJU5O1A5ZV C88X29Y479 HF539G9L3Q 498M34P1VZ CZD6M4PY4B E4GA8884NN 27YLU75U4W 0KD7R09EAS 42QO5P0NLM H6241UJ22B 0B4FDL9I6P RQ2CFA7WWJ
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class MOA:	Adrenergic alpha-Agonists [MoA] Adrenergic beta-Agonists [MoA]
Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`.
Pharmacologic Class EPC:	Standardized Chemical Allergen [EPC] alpha-Adrenergic Agonist [EPC] beta-Adrenergic Agonist [EPC] Catecholamine [EPC] Non-Standardized Food Allergenic Extract [EPC] Non-Standardized Plant Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:	Increased Histamine Release [PE] Cell-mediated Immunity [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:	Allergens [CS] Catecholamines [CS] Dietary Proteins [CS] Plant Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Adrenergic alpha-Agonists [MoA] Adrenergic beta-Agonists [MoA] Allergens [CS] Antimalarial [EPC] Calculi Dissolution Agent [EPC] Catecholamine [EPC] Catecholamines [CS] Cell-mediated Immunity [PE] Dietary Proteins [CS] Increased Histamine Release [PE] Increased Large Intestinal Motility [PE] Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] Inhibition Small Intestine Fluid/Electrolyte Absorption [PE] Magnesium Ion Exchange Activity [MoA] Non-Standardized Food Allergenic Extract [EPC] Non-Standardized Plant Allergenic Extract [EPC] Osmotic Activity [MoA] Osmotic Laxative [EPC] Plant Proteins [CS] Standardized Chemical Allergen [EPC] Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] alpha-Adrenergic Agonist [EPC] beta-Adrenergic Agonist [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
63479-0202-1	30 mL in 1 BOTTLE, GLASS (63479-0202-1)	15 Dec, 1994	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

B02 Adrenal Pep

Aceticum Acidum & more..

Solution/ Drops
Apex Energetics Inc.
NDC: 63479-0202

Purpose:

Uses: for temporary relief of minor: tiredness* sadness* restlessness* exhaustion* sleepiness* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Product Elements:

B02 adrenal pep aceticum acidum, adrenalinum, american ginseng, arnica montana, balsamum peruvianum, bos taurus pituitarum posterium, cherry plum flower, chininum arsenicosum, cinchona officinalis, clematis vitalba flower, damiana, european hornbeam flower, european olive flower, glycyrrhiza glabra, impatiens glandulifera flower, kali phosphoricum, lycopodium clavatum, magnesia phosphorica, phosphoricum acidum, phosphorus, pyrenees star of bethlehem, rockrose flower, selenium metallicum, thyroidinum epinephrine epinephrine dibasic potassium phosphate phosphate ion lycopodium clavatum spore lycopodium clavatum spore phosphoric acid phosphoric acid turnera diffusa leafy twig turnera diffusa leafy twig water balsam peru balsam peru quinine arsenite quinine clematis vitalba flower clematis vitalba flower carpinus betulus flower carpinus betulus flower glycyrrhiza glabra glycyrrhiza glabra impatiens glandulifera flower impatiens glandulifera flower helianthemum nummularium flower helianthemum nummularium flower selenium selenium magnesium phosphate, dibasic trihydrate magnesium cation ornithogalum umbellatum flowering top ornithogalum umbellatum flowering top thyroid, unspecified thyroid, unspecified phosphorus phosphorus bos taurus pituitary gland, posterior bos taurus pituitary gland, posterior olea europaea flower olea europaea flower prunus cerasifera flower prunus cerasifera flower alcohol cinchona officinalis bark cinchona officinalis bark acetic acid acetic acid american ginseng american ginseng arnica montana arnica montana

Indications and Usage:

Uses: for temporary relief of minor: tiredness* sadness* restlessness* exhaustion* sleepiness* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Warnings:

Warnings: if pregnant or breastfeeding , ask a health professional before use. do not use if clear seal over the cap is broken or missing. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. stop use and ask a doctor if tiredness, sadness, restlessness, exhaustion, sleepiness, or other symptoms do not improve within 7 days or are accompanied by fever.

Dosage and Administration:

Adults & children ages 12 years and over: take 10-15 drops under the tongue 3-4 times a day, or as directed by your healthcare professional. consult a physician for use in children under 12 years of age.

Stop Use:

Stop use and ask a doctor if tiredness, sadness, restlessness, exhaustion, sleepiness, or other symptoms do not improve within 7 days or are accompanied by fever.

Package Label Principal Display Panel:

FutureplexÂ® b02 antitoxÂ® adrenal pepâ¢ homeopathic formula tiredness* sadness* restlessness* 1 fl oz (30 ml) alcohol 20% by volume b02 adrenal pep label.jpg

Further Questions:

Distributed by apex energetics. questions? 16592 hale ave., irvine, ca 92606, usa

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.